Description

3-(3-Bromo-Phenyl)-3A,4,6,6A-Tetrahydro-Thieno[3,4-D]Isoxazole 5,5-Dioxide is a high-purity, advanced pharmaceutical intermediate of significant interest in modern synthetic chemistry. Its core value lies in its unique fused heterocyclic structure, which serves as a critical building block for the development of novel active pharmaceutical ingredients (APIs). This compound is primarily needed by research institutions and pharmaceutical companies engaged in the synthesis of complex molecules for drug discovery and development programs, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of novel drug candidates, especially those targeting the central nervous system.
• Medicinal Chemistry Research: Used as a versatile scaffold for constructing complex heterocyclic libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Organic Synthesis Building Block: Employed in advanced organic reactions, including cross-coupling and cycloaddition, to create new chemical entities.
• Agrochemical Research: Potential application as an intermediate in the development of new generation herbicides or fungicides with novel modes of action.
• Material Science Exploration: Investigated for the synthesis of specialized organic electronic materials due to its electron-deficient sulfone and heterocyclic components.

Basic Information

Product Name	3-(3-Bromo-Phenyl)-3A,4,6,6A-Tetrahydro-Thieno[3,4-D]Isoxazole 5,5-Dioxide
CAS No.	910442-25-0
Molecular Formula	C11H8BrNO3S
Molecular Weight	314.16 g/mol
Synonyms	3-(3-Bromophenyl)-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]isoxazole 5,5-dioxide; 3-(3-Bromophenyl)hexahydrothieno[3,4-d]isoxazole 5,5-dioxide; 910442-25-0; Thieno[3,4-d]isoxazole, 3-(3-bromophenyl)hexahydro-, 5,5-dioxide; 3-(3-Bromo-phenyl)-3a,4,6,6a-tetrahydro-thieno[3,4-d]isoxazole-5,5-dioxide
EINECS	Contact for details

Quality Control

Our production of 3-(3-Bromo-Phenyl)-3A,4,6,6A-Tetrahydro-Thieno[3,4-D]Isoxazole 5,5-Dioxide adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound should be handled as moisture-sensitive. Keep away from incompatible materials such as strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.